Floatz logo

465 assets in Obesity Disorder

Therapeutic assets addressing Obesity Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dwrx5003
Obesity Disorder
Daewoong Pharmaceutical Co. LTD.P1CC (41)
EMP 22
Obesity Disorder
Empros Pharma ABP1CC (41)
Hrs-5817
Obesity Disorder
Atridia Pty Ltd.P1CC (41)
Human Growth Hormone
Obesity Disorder
Columbia UniversityP1CC (41)
ibi3032
Obesity Disorder
Innovent Biologics Technology Limited (Shanghai R&D Center)P1CC (41)
kn069
Obesity Disorder
Suzhou Alphamab Co., Ltd.P1CC (41)
ly4064912
Obesity Disorder
Eli Lilly and CompanyP1CC (41)
mwn109
Obesity Disorder
Shanghai Minwei Biotechnology Co., LtdP1CC (41)
Normal Human Serum Albumin
Obesity Disorder
Columbia UniversityP1CC (41)
Phentolamine
Obesity Disorder
University of Missouri-ColumbiaP1CC (41)
Regn20934
Obesity Disorder
Regeneron PharmaceuticalsP1CC (41)
syh9017
Obesity Disorder
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.P1CC (41)
Talfirastide
Obesity Disorder
Milton S. Hershey Medical CenterP1CC (41)
TIX100
Obesity Disorder
TIXiMED, Inc.P1CC (41)
Aln-2232
Obesity Disorder
Alnylam PharmaceuticalsP1/2CC (40)
Apsolol
Obesity Disorder
University of Missouri-ColumbiaEarly P1CC (40)
Aro-Alk7
Obesity Disorder
Arrowhead PharmaceuticalsP1/2CC (40)
Aro-Inhbe
Obesity Disorder
Arrowhead PharmaceuticalsP1/2CC (40)
Colulintide
Obesity Disorder
Eli Lilly and CompanyP1CC (40)
Deltagold® Tocotrienol 70%
Obesity Disorder
Texas Tech University Health Sciences CenterP1/2CC (40)
Drospirenone
Obesity Disorder
Eli Lilly and CompanyP1CC (40)
Exendin-4 Fc Fusion Protein
Obesity Disorder
Beijing Dongfang Biotech Co., Ltd.P1CC (40)
Genistein
Obesity Disorder
Western UniversityP1/2CC (40)
gub014295
Obesity Disorder
AbbVieP1CC (40)
LEAP2
Obesity Disorder
University Hospital, Gentofte, CopenhagenP1/2CC (40)
Nisostirotide
Obesity Disorder
Eli Lilly and CompanyP1CC (40)
Amg 786
Obesity Disorder
AmgenP1C (39)
bi 3006337
Obesity Disorder
Boehringer IngelheimP1C (39)
Ent-03
Obesity Disorder
Metabolics PharmaP1C (39)
Epinephrine
Obesity Disorder
IVO JURISICEarly P1C (39)
Gip
Obesity Disorder
Novo Nordisk A/SP1C (39)
Glucagon-Like Peptide 1, Human
Obesity Disorder
Indiana UniversityP1C (39)
Hcr-188
Obesity Disorder
Helicore Biopharma, Inc.Early P1C (39)
hec88473
Obesity Disorder
Dongguan HEC Biopharmaceutical R&D Co., Ltd.P1C (39)
High Oleic Soybean Oil (Unhydrogenated)
Obesity Disorder
University of OklahomaEarly P1C (39)
Insulin Human
Obesity Disorder
Columbia UniversityP1C (39)
Lotiglipron
Obesity Disorder
PfizerP2C (39)
Monlunabant
Obesity Disorder
Novo Nordisk A/SP1C (39)
pf-06954522
Obesity Disorder
PfizerP1C (39)
t2026
Obesity Disorder
Sciwind Biosciences APAC CO Pty. Ltd.P1C (39)
Crocus Sativus Tepals Cold Aqueous Extract
Obesity Disorder
University of PrimorskaEarly P1C (38)
ly3537031
Obesity Disorder
Eli Lilly and CompanyP1C (37)
ly4086940
Obesity Disorder
Eli Lilly and CompanyP1C (37)
ly4167586
Obesity Disorder
Eli Lilly and CompanyP1C (37)
nnc0497-0040
Obesity Disorder
Novo Nordisk A/SP1C (37)
nnc6989-0001 a
Obesity Disorder
Novo Nordisk A/SP1C (37)
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER
Obesity Disorder
Duke UniversityP1C (36)
Abbv-295
Obesity Disorder
AbbVieP1C (36)
Aln-6222
Obesity Disorder
Alnylam PharmaceuticalsP1C (36)
azd1043
Obesity Disorder
AstraZenecaP1C (36)
Showing 301 to 350 of 465 assets
PreviousPage 7 of 10Next